These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8463474)

  • 21. [Myasthenia gravis associated with penicillamine treatment].
    Medrano San Ildefonso M; Mauri Llerda JA; Orte Martínez J
    Arch Neurobiol (Madr); 1987; 50(4):272-3. PubMed ID: 3662740
    [No Abstract]   [Full Text] [Related]  

  • 22. Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatoid arthritis.
    Hearn J; Tiliakos NA
    South Med J; 1986 Sep; 79(9):1185-6. PubMed ID: 3750012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 25. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

  • 29. D-penicillamine induced myasthenia gravis. Its relevance for the anaesthetist.
    Fried MJ; Protheroe DT
    Br J Anaesth; 1986 Oct; 58(10):1191-3. PubMed ID: 3768231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-Penicillamine--induced pemphigus syndrome.
    Yung CW; Hambrick GW
    J Am Acad Dermatol; 1982 Mar; 6(3):317-24. PubMed ID: 7068961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC; Balint G; Dawkins RL
    Scand J Rheumatol Suppl; 1979; (28):91-3. PubMed ID: 287196
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.
    Seideman P; Ayesh R
    Clin Rheumatol; 1994 Sep; 13(3):435-7. PubMed ID: 7835005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myasthenia syndrome after peroral treatment with penicillamine].
    Francois J; Verbraeken H; Gabriel P; Wille C
    Ophthalmologica; 1978; 177(2):88-91. PubMed ID: 745827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease.
    Adelman HM; Winters PR; Mahan CS; Wallach PM
    Am J Med Sci; 1995 Apr; 309(4):191-3. PubMed ID: 7900739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The toxicity of D-penicillamine in systemic sclerosis.
    Steen VD; Blair S; Medsger TA
    Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 37. [D-penicillamine-induced myasthenia gravis].
    Murros K; Möttönen T
    Duodecim; 1984; 100(5):292-4. PubMed ID: 6714116
    [No Abstract]   [Full Text] [Related]  

  • 38. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F; Menkes CJ; Sainte-Croix A; Delbarre F; Babinet P; Chesneau AM
    Nouv Presse Med; 1975 Nov; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myasthenia gravis caused by D-penicillamine].
    Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
    Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
    [No Abstract]   [Full Text] [Related]  

  • 40. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor.
    Russell AS; Lindstrom JM
    Neurology; 1978 Aug; 28(8):847-9. PubMed ID: 567304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.